Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sales

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
JAMA|June 11, 1997
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectI M Graham, L E Daly, H M Refsum, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Diversity of ancestral brainstem noradrenergic neurons across species and multiple biological factorsMichael A Kelberman, Ellen Rodberg, Ehsan Arabzadeh, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, BrazilNuno R Faria, Thomas A Mellan, Charles Whittaker, et al.
American Heart Journal|May 16, 2016
Corrigendum to 'The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)' [American Heart Journal 171/1 (2016) 73-81]Bernardete Weber, Ângela C Bersch-Ferreira, Camila R Torreglosa, et al.
American Heart Journal|December 25, 2015
The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)Bernardete Weber, Ângela Cristine Bersch-Ferreira, Camila Ragne Torreglosa, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
JAMA|June 11, 1997
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectI M Graham, L E Daly, H M Refsum, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Diversity of ancestral brainstem noradrenergic neurons across species and multiple biological factorsMichael A Kelberman, Ellen Rodberg, Ehsan Arabzadeh, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, BrazilNuno R Faria, Thomas A Mellan, Charles Whittaker, et al.
American Heart Journal|May 16, 2016
Corrigendum to 'The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)' [American Heart Journal 171/1 (2016) 73-81]Bernardete Weber, Ângela C Bersch-Ferreira, Camila R Torreglosa, et al.
American Heart Journal|December 25, 2015
The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)Bernardete Weber, Ângela Cristine Bersch-Ferreira, Camila Ragne Torreglosa, et al.
Pageof 17